Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome

By Yarali H.   Yildirir A.   Aybar F.   Kabakci G.   Bukulmez O.   Akgul E.   Oto A.  

Fertility and Sterility, Vol. 76, Iss. 3, 2001-09 ,pp. : 511-516

Elsevier

Access to resources Recommend Favorite

Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?

By Loucks T.L.   Talbott E.O.   McHugh K.P.   Keelan M.   Berga S.L.   Guzick D.S.  

Fertility and Sterility, Vol. 74, Iss. 3, 2000-09 ,pp. : 547-552

Elsevier

Access to resources Recommend Favorite

Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors

By Lakhani K   Prelevic GM   Seifalian AM   Atiomo WU   Hardiman P  

Journal of Obstetrics & Gynaecology, Vol. 24, Iss. 6, 2004-09 ,pp. : 613-621

Informa Healthcare

Access to resources Recommend Favorite

To determine whether first-degree male relatives of women with polycystic ovary syndrome are at higher risk of developing cardiovascular disease and type II diabetes mellitus

By Hunter A.   Vimplis S.   Sharma A.   Eid N.   Atiomo W.  

Journal of Obstetrics & Gynaecology, Vol. 27, Iss. 6, 2007-01 ,pp. : 591-596

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular risk and events in polycystic ovary syndrome

By Carmina E.  

Climacteric, Vol. 12, Iss. 1, 2009-08 ,pp. : 22-25

Informa Healthcare

Access to resources Recommend Favorite